Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Fully human anti-ICAM antibody effective in murine psoriasis model

July 23, 2004

Enrollment completed for Fibrostat phase IIb study

July 22, 2004

Promising vitamin D analogue for the treatment of psoriasis

July 21, 2004

FDA Advisory Committee recommends against approval of oral tazarotene

July 16, 2004

Studies highlight pimecrolimus efficacy in children with atopic dermatitis

July 14, 2004

Tacrolimus results presented at pediatric dermatology congress

July 13, 2004

Positive phase II results for Allox

July 13, 2004

Sumitomo discloses agents for fibrosis in patent literature

July 6, 2004

Novartis claims steryl sulfatase inhibitors with utility in acne therapy

June 30, 2004

NICE recommends use of Elidel for atopic eczema

June 30, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...